• Accera Inc., of Broomfield, Colo., appointed Holger Kunze CEO and board member. It also named Sven Thormahlen to the board.

• Adeona Pharmaceuticals Inc., of Ann Arbor, Mich., appointed John Monahan senior vice president of R&D.

• Advanced Cell Technology Inc., of Marlborough, Mass., named Gregory D. Perry and Zohar Loshitzer to its board.

• Affimed Therapeutics AG, of Heidelberg, Germany, named Eugene Zhukovsky chief scientific officer.

• Agensys Inc., of Santa Monica, Calif., a subsidiary of Astellas Inc., appointed Frank P. Hudson vice president of finance and named Wolfgang Noe vice president of process sciences and manufacturing.

• Amarantus BioSciences Inc., of Sunnyvale, Calif., added Mark J. Benedyk as strategic advisor.

• Ambit Biosciences Inc., of San Diego, appointed Michael A. Martino president, CEO and board member.

• AM-Pharma BV, of Bunnik, the Netherlands, appointed Russell Greig chairman.

• AmpliPhi Biosciences Corp., of Seattle, appointed Philip J. Young president and CEO.

• Anthera Pharmaceuticals Inc., of Hayward, Calif., promoted Debra Odink to chief technology officer and senior vice president.

• ATyr Pharma Inc., of San Diego, appointed R. Alan Ezekowitz to its therapeutic advisory board.

• Auxilium Pharmaceuticals Inc., of Malvern, Pa., appointed Adrian Adams president, CEO and board member.

• AVI BioPharma Inc., of Bothell, Wash., appointed Jayant Aphale senior vice president of technical operations.

• Biocartis, of Lausanne, Switzerland, appointed Nayan Gregory Parekh CEO.

• Bionovo Inc., of Emeryville, Calif., added David Boyle as senior vice president and chief financial officer.

• BioSpecifics Technologies Corp., of Lynbrook, N.Y., appointed George Gould to its board.

• BioTime Inc., of Alameda, Calif., and its subsidiary, OncoCyte Corp., each appointed Andrew von Eschenbach to their boards.

• Boston Therapeutics Inc., of Manchester, N.H., elected Henry J. Esber to its board.

• Catalyst Pharmaceutical Partners Inc., of Coral Gables, Fla., named Richard P. Rieger vice president of commercial operations. Catalyst also promoted Alicia Grande to vice president, chief financial officer and treasurer.

• CBio Ltd., of Brisbane, Australia, named Ralph Craven chairman and appointed Helen Cameron interim managing director.

• Cerenis Therapeutics, of Toulouse, France, appointed John F. Paolini chief medical officer and named Richard C. Pasternak to its board.